KA-10X

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameKA-10X
Drug Alias NameG3BP antagonist peptides (Wuhan KatyGen Pharmaceuticals)AnkelitaiRasGAP/RasGAP binding protein antagonist peptides (Wuhan Katygen Pharmaceuticals)KA-101KA-102 +[6] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGTPase Ras modulators
TargetsGTPase Ras
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesWuhan KatyGen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWuhan KatyGen Pharmaceuticals IncHuya Bioscience International Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A